Satsuma Pharmaceuticals Stock Price - STSA

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Satsuma Pharmaceuticals Inc STSA NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  -0.32 -2.79% 11.13 11.65 11.0001 11.65 11.45 16:30:00
Bid Price Ask Price Spread Spread % News
10.60 11.40 0.80 7.02% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
210 18,842 $ 11.27 $ 212,303 107,190 8.61 - 19.66
Last Trade Time Type Quantity Stock Price Currency
16:00:01 1 $ 11.13 USD

Satsuma Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 184.82M 16.61M $ 385.72M -1.86 - 16.61M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Satsuma Pharmaceuticals News

Loading Messages....

Latest STSA Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical STSA Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week9.3812.979.094510.8438,4141.7518.66%
1 Month15.0015.478.6111.3068,339-3.87-25.8%
3 Months19.0019.668.6113.4594,248-7.87-41.42%
6 Months19.0019.668.6113.4594,248-7.87-41.42%
1 Year19.0019.668.6113.4594,248-7.87-41.42%
3 Years19.0019.668.6113.4594,248-7.87-41.42%
5 Years19.0019.668.6113.4594,248-7.87-41.42%

Satsuma Pharmaceuticals Description

Satsuma Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product for the treatment of migraine. Its product candidate, STS101, is a drug-device combination of a dry-powder formulation of dihydroergotamine mesylate, or DHE, which can be self-administered with a pre-filled, single-use, nasal delivery device.


Your Recent History
NASDAQ
STSA
Satsuma Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.